(BTAI) Bioxcel Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Bioxcel Therapeutics | (BTAI) share price targets
Complete technical analysis of Bioxcel Therapeutics (BTAI) by charts plus indicators, forecast predictions and share price targets for Bioxcel Therapeutics (BTAI)
Bioxcel Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Bioxcel Therapeutics is 677832
| Date | Daily Closing Price | Open | High | Low | Volume |
| 07 Fri Nov 2025 | 1.84 | 1.78 | 1.88 | 1.68 | 1.108 times |
| 06 Thu Nov 2025 | 1.78 | 1.87 | 1.88 | 1.75 | 0.782 times |
| 05 Wed Nov 2025 | 1.86 | 1.86 | 1.93 | 1.83 | 0.859 times |
| 04 Tue Nov 2025 | 1.87 | 1.88 | 2.00 | 1.84 | 0.845 times |
| 31 Fri Oct 2025 | 2.05 | 2.04 | 2.07 | 1.98 | 0.821 times |
| 31 Fri Oct 2025 | 2.05 | 2.04 | 2.07 | 1.98 | 0.821 times |
| 30 Thu Oct 2025 | 2.02 | 2.08 | 2.15 | 1.98 | 1.231 times |
| 29 Wed Oct 2025 | 2.07 | 2.18 | 2.18 | 2.05 | 1.316 times |
| 28 Tue Oct 2025 | 2.18 | 2.28 | 2.29 | 2.15 | 1.108 times |
| 27 Mon Oct 2025 | 2.28 | 2.34 | 2.40 | 2.26 | 1.104 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 1.9, but if it comes above 1.9, then a intra day buy could be more profitable.
If you take a sell trade below 1.9, then use 1.9 as stoploss and 1.6 as target. However if you take a buy trade in stock , then use 1.9 as stoploss and 2.2 as target.
Share price targets for Bioxcel Therapeutics (BTAI)
| Target Type | Value |
| Downside Target | 1.30 |
| Downside Target | 1.33 |
| Downside Target | 1.68 |
| Upside Target | 1.98 |
| Upside Target | 2.07 |
| Upside Target | 2.13 |
| Upside Target | 2.26 |
| Upside Target | 2.40 |
| Upside Target | 2.46 |
| Upside Target | 2.47 |
| Upside Target | 2.76 |
| Upside Target | 2.87 |
| Upside Target | 4.29 |
| Upside Target | 8.08 |
Intraday share price targets for Bioxcel Therapeutics (BTAI)
| Target Type | Value |
| Downside Intraday Target | 1.68 |
| Downside Intraday Target | 1.52 |
| Upside Intraday Target | 2 |
| Upside Intraday Target | 2.16 |
| Downside Intraday Target | 1.84 |
Weekly technical analysis of Bioxcel Therapeutics (BTAI)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 07 Fri Nov 2025 | 1.84 | 1.88 | 2.00 | 1.68 | 4.378 times |
| 31 Fri Oct 2025 | 2.05 | 2.04 | 2.07 | 1.98 | 0.147 times |
| 31 Fri Oct 2025 | 2.05 | 2.34 | 2.40 | 1.98 | 1.122 times |
| 24 Fri Oct 2025 | 2.34 | 2.32 | 2.46 | 2.13 | 0.668 times |
| 17 Fri Oct 2025 | 2.30 | 2.57 | 2.76 | 2.26 | 0.721 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Bioxcel Therapeutics (BTAI)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 07 Fri Nov 2025 | 1.84 | 1.88 | 2.00 | 1.68 | 0.106 times |
| 31 Fri Oct 2025 | 2.05 | 2.50 | 2.87 | 1.98 | 0.542 times |
| 30 Tue Sep 2025 | 2.56 | 3.98 | 4.29 | 2.47 | 0.087 times |
| 29 Fri Aug 2025 | 4.05 | 1.66 | 8.08 | 1.33 | 65.899 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Bioxcel Therapeutics (BTAI)
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Bioxcel Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Bioxcel Therapeutics in short term and the sell signal is strong.
Bioxcel Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Bioxcel Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Bioxcel Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.01 and Bioxcel Therapeutics (BTAI) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Bioxcel Therapeutics (BTAI) stock. Volume based technical analysis of Bioxcel Therapeutics (BTAI) stock is negative.
Bioxcel Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Bioxcel Therapeutics ( (BTAI) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Bioxcel Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Bioxcel Therapeutics in short term and the sell signal is strong.
Bioxcel Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Bioxcel Therapeutics in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Bioxcel Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.01 and Bioxcel Therapeutics (BTAI) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Bioxcel Therapeutics (BTAI) stock. Volume based technical analysis of Bioxcel Therapeutics (BTAI) stock is negative.
Bioxcel Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.